Near-infrared spectroscopy-derived lipid core burden index predicts adverse cardiovascular outcome in patients with coronary artery disease during long-term follow-up

COMMENTED

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Circulation.

Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS

doi: 10.1161/CIRCULATIONAHA.

Diabetes - GeneralType 2 Diabetes

CT Angiography Images of Coronary Artery Stenosis Provide a Better Prediction of Risk Than Traditional Risk Factors in Asymptomatic Individuals With Type 2 Diabetes: A Long-term Study of Clinical Outcomes

Diabetes Care.

Lee KY, Hwang BH, Kim TH, Kim CJ, Kim JJ, Choo EH, Choi IJ, Choi Y, Park HW, Koh YS, Kim PJ, Lee JM, Kim MJ, Jeon DS, Cho JH, Jung JI, Seung KB, Chang K

doi: 10.2337/

Further Publications

Echocardiographic predictors of long-term adverse cardiovascular outcomes in patients with and without diabetes mellitus: a follow-up analysis of the Copenhagen City Heart Study

Diabet Med

Özbek BT, Modin D, Møgelvang R, Jørgensen PG, Jensen MT, Schnohr P, Gislason GH, Biering-Sørensen T

doi: 10.1111/dme.14627

Diabetes - General

Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium

Circulation.

Goldberg RB, Aroda VR, Bluemke DA, Barrett-Connor E, Budoff MJ, Crandall JP, Dabelea D, Horton ES, Mather KJ, Orchard TJ, Schade D, Watson K, Temprosa M; Diabetes Prevention Program Research Group

doi: 10.1161/CIRCULATIONAHA.

COMMENTED

Type 1 Diabetes

The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes

Diabetologia.

Guo J, Erqou SA, Miller RG, Edmundowicz D, Orchard TJ, Costacou T

doi: 10.1007/s00125-018-4764-2.

Diabetes - GeneralType 2 Diabetes

Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

Cardiovasc Diabetol

Li M, Duan L, Cai Y, Hao B, Chen J, Li H, Liu H

doi: 10.1186/s12933-021-01244-3

Diabetes - General

Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency

J Am Coll Cardiol.

Raza S, Blackstone EH, Houghtaling PL, Rajeswaran J, Riaz H, Bakaeen FG, Lincoff AM, Sabik JF 3rd

doi: 10.1016/j.jacc.2017.05.061.

COMMENTED

Diabetes - General

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Lancet Diabetes Endocrinol.

Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG, ODYSSEY OUTCOMES Committees and Investigators.

doi: 10.1016/S2213-8587(19)30158-5.

Diabetes - GeneralType 2 Diabetes

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial

Diabetologia.

Verma S, Mazer CD, Fitchett D, Inzucchi SE, Pfarr E, George JT, Zinman B

doi: 10.1007/s00125-018-4644-9.

Related content

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

CT Angiography Images of Coronary Artery Stenosis Provide a Better Prediction of Risk Than Traditional Risk Factors in Asymptomatic Individuals With Type 2 Diabetes: A Long-term Study of Clinical Outcomes

Echocardiographic predictors of long-term adverse cardiovascular outcomes in patients with and without diabetes mellitus: a follow-up analysis of the Copenhagen City Heart Study

Effect of Long-term Metformin and Lifestyle in the Diabetes Prevention Program and its Outcome Study on Coronary Artery Calcium

The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetes

Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial